Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies (vol 20, pg 589, 2017)

被引：0
|
作者：
Wei, J. C. C. [1 ]
Baeten, D. [1 ]
Sieper, J. [1 ]
Deodhar, A. [1 ]
Bhosekar, V [1 ]
Martin, R. [1 ]
Porter, B. [1 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2017年 / 20卷 / 07期
关键词：
D O I：
10.1111/1756-185X.13154
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：911 / 911
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies
    Wei, James C. -C.
    Baeten, Dominique
    Sieper, Joachim
    Deodhar, Atul
    Bhosekar, Vaishali
    Martin, Ruvie
    Porter, Brian
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (05) : 589 - 596
  • [2] Reduction in fatigue in patients with active ankylosing spondylitis: results of two phase 3 studies of secukinumab
    Kvien, T. K.
    Conaghan, P.
    Deodhar, A.
    Gossec, L.
    Ostergaard, M.
    Canete, J.
    Gandhi, K.
    Richards, H.
    Williams, N.
    Jugl, S.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 35 - 36
  • [3] REDUCTION IN FATIGUE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF TWO PHASE 3 STUDIES OF SECUKINUMAB
    Kvien, T. K.
    Conaghan, P. G.
    Deodhar, A.
    Gossec, L.
    Ostergaard, M.
    Canete, J.
    Gandhi, K.
    Richards, H.
    Williams, N.
    Jugl, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 823 - 823
  • [4] Safety and Tolerability of Secukinumab in Patients with Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials
    Deodhar, Atul A.
    Baeten, Dominique
    Sieper, Joachim
    Porter, Brian
    Widmer, Albert
    Richards, Hanno
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials
    Kyburz, D.
    Deodhar, A.
    Baeten, D.
    Sieper, J.
    Porter, B.
    Widmer, A.
    Richards, H.
    [J]. SWISS MEDICAL WEEKLY, 2016, 146 : 6S - 6S
  • [6] Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies
    McInnes, Iain B.
    Mease, Philip J.
    Tanaka, Yoshiya
    Gossec, Laure
    Husni, M. Elaine
    Kristensen, Lars Erik
    Warren, Richard B.
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Gottlieb, Alice B.
    [J]. ACR OPEN RHEUMATOLOGY, 2024,
  • [7] SAFETY AND TOLERABILITY OF SECUKINUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POOLED SAFETY ANALYSIS OF TWO INTERNATIONAL PHASE 3, RANDOMIZED, CONTROLLED TRIALS
    Deodhar, Atul
    Baeten, Dominique
    Sieper, Joachim
    Porter, Brian
    Richards, Hanno
    Widmer, Albert
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 139 - 140
  • [8] The Impact of Age and Time Since Diagnosis on Response to Treatment with Secukinumab in Pooled Week 52 Data from 4 Phase 3 Studies in Patients with Ankylosing Spondylitis
    Deodhar, Atul
    Mease, Philip
    Machado, Paula
    Pournara, Effie
    Meng, Xiangyi
    Strand, Vibeke
    Magrey, Marina
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] ASAS, BASDAI AND ASDAS REMISSION IN SECUKINUMAB TREATED PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A POOLED ANALYSIS OF TWO PHASE 3 STUDIES
    Baraliakos, X.
    Van den Bosch, F.
    Machado, P.
    Gensler, L.
    Bintu, S.
    Porter, B.
    Gaillez, C.
    Deodhar, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 743 - 743
  • [10] Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
    Baraliakos, Xenofon
    Van den Bosch, Filip
    Machado, Pedro M.
    Gensler, Lianne S.
    Marzo-Ortega, Helena
    Sherif, Bintu
    Quebe-Fehling, Erhard
    Porter, Brian
    Gaillez, Corine
    Deodhar, Atul
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 273 - 288
12345